HCD economics has conducted studies in to many bleeding/blood disorders including Haemophilia, Sickle Cell Disease and Von Willebrand Disease.


Haemophilia is a genetic disorder characterised by a deficiency of a clotting factor in the blood, leading to prolonged bleed events. The disease is carried on the X chromosome and primarily affects males, though female carriers of the gene may exhibit symptoms of mild haemophilia. The two forms of the condition are Haemophilia A (Factor VIII (FVIII) deficiency) and Haemophilia B (Factor IX (FIX) deficiency); Haemophilia A is approximately four times more common than Haemophilia B 
HCD Economics has conducted the largest ever burden of disease study in Europe and continues to build on this, with over 3,000 patients and 350 physicians involved in our research to date. This research has subsequently seen the publication of several peer reviewed manuscripts, dozens of congress abstracts/posters and the data used to support development of policy in the EU and US.